News | December 30, 2023
Venus Remedies secures marketing approval from Israel, Colombia for two oncology drugs
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
He was appointed a Board member and the Chairman in 2012.
A research group led by Ben-Gurion University of the Negev managed to produce an innovative microchip for creating sperm in a culture by using a microfluidic system.
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.
The data driven fertility company helps increase the success rate of fertility treatments
Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
It would be the first protein-based alternative available in Israel
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)